Provided by Tiger Trade Technology Pte. Ltd.

Vera Therapeutics, Inc.

33.50
-0.2800-0.83%
Volume:1.10M
Turnover:37.13M
Market Cap:2.40B
PE:-5.68
High:34.28
Open:33.42
Low:33.20
Close:33.78
52wk High:56.05
52wk Low:22.72
Shares:71.71M
Float Shares:52.39M
Volume Ratio:1.04
T/O Rate:2.10%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.8984
EPS(LYR):-4.6644
ROE:-91.75%
ROA:-46.76%
PB:5.89
PE(LYR):-7.18

Loading ...

Maintaining a Buy on Vera: Commercial-Stage Transition and Trutakna Strength Support Unchanged $90 Price Target

TIPRANKS
·
Jul 08

Vera Therapeutics Exec Says Trutakna's Wholesale Acquisition Cost for Four Doses or 28-day Supply is $32,700 - Conf Call

THOMSON REUTERS
·
Jul 08

Vera Therapeutics is Maintained at Buy by B of a Securities

Dow Jones
·
Jul 08

Under the Radar: Vera Stock Jumps as Kidney-disease Drug Approved by FDA

Dow Jones
·
Jul 08

Vera Therapeutics price target raised to $70 from $65 at BofA

TIPRANKS
·
Jul 08

Vera Therapeutics gains FDA nod for TRUTAKNA launch

TIPRANKS
·
Jul 08

Vera Therapeutics' Drug to Reduce Proteinuria Gets FDA Approval

MT Newswires Live
·
Jul 08

US FDA Approves Vera's Kidney Disease Drug

Reuters
·
Jul 08

Vera Wins FDA Accelerated Approval for Trutakna in Primary Iga Nephropathy Based on 42% Proteinuria Cut in Phase 3 Trial

Reuters
·
Jul 08

Vera Therapeutics Receives FDA Accelerated Approval for Trutakna™ for Adult Patients with Primary Iga Nephropathy

THOMSON REUTERS
·
Jul 08

Vera Therapeutics Receives FDA Accelerated Approval for TRUTAKNA™ for Adult Patients with Primary IgA Nephropathy

GlobeNewswire
·
Jul 08

US FDA - Approves Trutakna for Proteinuria in Primary Immunoglobulin a Nephropathy

THOMSON REUTERS
·
Jul 08

Press Release: Robinson Energy Appoints Iraida QUE DE VERA to ITS BOARD of Directors

Dow Jones
·
Jul 07

Vera Therapeutics CEO Marshall Fordyce Disposes of USD 702,065 in Common Shares

Reuters
·
Jun 25

Vera Therapeutics (VERA) Stock After FDA Trial Update Has The Valuation Gap Gone Too Far

Simply Wall St.
·
Jun 17

Vera Therapeutics (VERA) Receives a Buy from Wells Fargo

TIPRANKS
·
Jun 12

Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
Jun 06

Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Jun 06

Analysts’ Top Healthcare Picks: Vera Therapeutics (VERA), Johnson & Johnson (JNJ)

TIPRANKS
·
Jun 06

Vera Therapeutics posts atacicept IgA nephropathy trial presentation

Reuters
·
Jun 05